Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
In TRUMPH-1: 2,339, randomised double-blind placebo-controlled participants with obesity or overweight without T2D were treated for 80 weeks with three dose arms: 4 mg, 9 mg, 12 mg vs placebo My key takeaways: - Weight loss at 80 weeks: -19.0% at 4 mg
R.TraxlerL.AgarwalR
doi:10.1111/j.1742-4658.2011.08358.x
What the Research Shows GLP-1 receptor agonists work by slowing gastric emptying, reducing appetite, and improving insulin sensitivity
Get your custom peptide protocol: Tailored to your body and goals Precise dosing and cycle length Safe stacking combinations Backed by peer-reviewed studies Ready in under 2 minutes What Pomegranate Health Actually Is Pomegranate Health operates in the telehealth-to-compounding-pharmacy model that became common during the 2022-2024 GLP-1 shortage
